-
-
-
-
-
-
-
Alkermes increases Avadel acquisition offer to $22.50 per share
-
-
-
-
-
-
-
Truist Securities Comments on Centessa Pharmaceuticals (CNTA) Amid 18pct Drop
-
-
-
-
-
-
-
Alkermes (ALKS) PT Raised to $42 at RBC Capital
-
-
-
-
-
-
-
RBC Capital Starts Alkermes (ALKS) at Sector Perform
-
-
-
-
-
-
-
Alkermes to Report Third Quarter Financial Results on October 24, 2024
-
-
-
-
-
-
-
Alkermes (ALKS) Misses Q4 EPS by 23c
-
-
-
-
-
-
-
Alkermes (ALKS) Tops Q2 EPS by 28c
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

